Meteoric Resources NL (ASX: MEI) (Meteoric or the Company) encloses a replacement ASX release relating to the updated Caldeira Scoping Study released…
Category:
Investing
-
-
-
-
Investing
Cardiol Therapeutics to Advance CardiolRx into a Late-Stage Trial in Patients with Recurrent Pericarditis
by adminMAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected to run…
-
-
-
-
-
InhaleRx Ltd (ASX: IRX) (‘InhaleRx’ ‘IRX’ or ‘the Company’), an Australian healthcare company developing unique drug-device products to address unmet medical needs…
-